Afya trades at a notably low forward P/E of 6.9x with a near-perfect Piotroski score and three beats in the last four quarters, but soft revenue growth and a momentum profile that has yet to recover above the long-term average require patience at entry.
Thesis pillars
- Momentum Below Entry Threshold→Stable
- High Quality Franchise Margins→Stable
- Deeply Discounted Valuation→Stable
- +2 more pillars — see the Why tab for full reasoning
Afya Limited (AFYA) Stock Analysis
Breakout setup · Inst Constrain edge
Consumer Defensive · Education & Training Services
Hold if already holding. Not a fresh buy at $15.20, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Weak growth.
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical... Read more
Hold if already holding. Not a fresh buy at $15.20, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Weak growth. Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Downgraded from BUY WAIT — price $15.27 has reached target $15.06. No upside to wait for. Score 5.8/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 39d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-07-06Recent Developments — Afya Limited
Latest news
- NEWS Afya Limited (AFYA) Faces Downward Pressure as Shares Decline 2.84% - Trade Entry Signals - thelegaladvocate.com — thelegaladvocate.com negative
- NEWS Afya Limited (AFYA) Faces Downward Pressure as Shares Decline 2.84% - Trade Entry Signals - The Legal Advocate — The Legal Advocate negative
- NEWS Afya Limited (AFYA) Faces Downward Pressure as Shares Decline 2.84% - Social Sentiment - thelegaladvocate.com — thelegaladvocate.com negative
- NEWS Afya Limited Q1 2026 Earnings: EPS Misses Estimates Amid Challenging Quarter - Energy Earnings Report - thelegaladvocate — thelegaladvocate.com negative
- NEWS Afya Limited Q1 2026 Earnings: EPS Misses Estimates Amid Challenging Quarter - Short-Term Outlook - thelegaladvocate.com — thelegaladvocate.com negative
Generated 2026-07-06T08:31:35Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $15.20, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Weak growth. Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Downgraded from BUY WAIT — price $15.27 has reached target $15.06. No upside to wait for. Target $15.06 (-0.9%), stop $13.05 (−16.5%), A.R:R -0.5:1. Score 5.8/10, moderate confidence.
Take-profit target: $15.06 (+10.2% upside). Target $15.06 (-0.9%), stop $13.05 (−16.5%), A.R:R -0.5:1. Stop-loss: $13.05.
Analyst target reached - limited upside remaining; Weak growth.
Afya Limited trades at a P/E of 9.5 (forward 7.8). TrendMatrix value score: 7.4/10. Verdict: Hold.
13 analysts cover AFYA with a consensus score of 2.5/5. Average price target: $17.
What does Afya Limited do?Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate,...
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy. The Continuing Education segment provides medical education, including residency preparation programs, specialization test preparation, graduate courses in medicine, and digital and in-person professional development for physicians and medical students. The Medical Practice Solutions segment offers clinical decision support platforms, medical practice management software, healthcare financial services, and digital healthcare ecosystem solutions, such as electronic medical records, practice management tools, telemedicine, digital prescriptions, and doctor-patient relationship platforms. This segment also provides a subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. The company also offers educational health and medical imaging; and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. In addition, it offers printed and digital content, as well as an online medical education platform and physicians, healthcare professionals and students. Afya Limited was founded in 1999 and is headquartered in Belo Horizonte, Brazil.